Logo image of DH

DEFINITIVE HEALTHCARE CORP (DH) Stock Fundamental Analysis

USA - NASDAQ:DH - US24477E1038 - Common Stock

4.15 USD
+0.02 (+0.48%)
Last: 9/12/2025, 8:00:01 PM
4.15 USD
0 (0%)
After Hours: 9/12/2025, 8:00:01 PM
Fundamental Rating

3

Overall DH gets a fundamental rating of 3 out of 10. We evaluated DH against 35 industry peers in the Health Care Technology industry. DH has a bad profitability rating. Also its financial health evaluation is rather negative. DH has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

DH had positive earnings in the past year.
DH had a positive operating cash flow in the past year.
In the past 5 years DH always reported negative net income.
Each year in the past 5 years DH had a positive operating cash flow.
DH Yearly Net Income VS EBIT VS OCF VS FCFDH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

DH has a worse Return On Assets (-39.57%) than 68.57% of its industry peers.
With a Return On Equity value of -100.37%, DH is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -39.57%
ROE -100.37%
ROIC N/A
ROA(3y)-16.45%
ROA(5y)-10.62%
ROE(3y)-39.07%
ROE(5y)-24.71%
ROIC(3y)N/A
ROIC(5y)N/A
DH Yearly ROA, ROE, ROICDH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

The Gross Margin of DH (76.35%) is better than 85.71% of its industry peers.
DH's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for DH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.22%
GM growth 5Y0.01%
DH Yearly Profit, Operating, Gross MarginsDH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

DH does not have a ROIC to compare to the WACC, probably because it is not profitable.
DH has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, DH has more shares outstanding
The debt/assets ratio for DH is higher compared to a year ago.
DH Yearly Shares OutstandingDH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
DH Yearly Total Debt VS Total AssetsDH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of -0.18, we must say that DH is in the distress zone and has some risk of bankruptcy.
DH has a Altman-Z score (-0.18) which is in line with its industry peers.
DH has a debt to FCF ratio of 4.10. This is a neutral value as DH would need 4.10 years to pay back of all of its debts.
DH has a better Debt to FCF ratio (4.10) than 62.86% of its industry peers.
DH has a Debt/Equity ratio of 0.53. This is a neutral value indicating DH is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.53, DH is not doing good in the industry: 68.57% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 4.1
Altman-Z -0.18
ROIC/WACCN/A
WACC9.26%
DH Yearly LT Debt VS Equity VS FCFDH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

DH has a Current Ratio of 1.65. This is a normal value and indicates that DH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.65, DH is doing worse than 65.71% of the companies in the same industry.
DH has a Quick Ratio of 1.65. This is a normal value and indicates that DH is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of DH (1.65) is worse than 65.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.65
DH Yearly Current Assets VS Current LiabilitesDH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

2

3. Growth

3.1 Past

DH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.09%.
Looking at the last year, DH shows a decrease in Revenue. The Revenue has decreased by -5.24% in the last year.
The Revenue has been growing by 24.15% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-9.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.22%
Revenue 1Y (TTM)-5.24%
Revenue growth 3Y14.91%
Revenue growth 5Y24.15%
Sales Q2Q%-4.69%

3.2 Future

DH is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.78% yearly.
Based on estimates for the next years, DH will show a decrease in Revenue. The Revenue will decrease by -0.46% on average per year.
EPS Next Y-32.85%
EPS Next 2Y-12.68%
EPS Next 3Y-4.78%
EPS Next 5YN/A
Revenue Next Year-4.79%
Revenue Next 2Y-2.09%
Revenue Next 3Y-0.46%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DH Yearly Revenue VS EstimatesDH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
DH Yearly EPS VS EstimatesDH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.83, which indicates a correct valuation of DH.
DH's Price/Earnings ratio is rather cheap when compared to the industry. DH is cheaper than 97.14% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. DH is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 15.55, which indicates a correct valuation of DH.
Based on the Price/Forward Earnings ratio, DH is valued cheaply inside the industry as 88.57% of the companies are valued more expensively.
DH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.83
Fwd PE 15.55
DH Price Earnings VS Forward Price EarningsDH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

DH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DH is cheaper than 88.57% of the companies in the same industry.
DH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DH is cheaper than 91.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.33
EV/EBITDA 10.35
DH Per share dataDH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

DH's earnings are expected to decrease with -4.78% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.68%
EPS Next 3Y-4.78%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DEFINITIVE HEALTHCARE CORP

NASDAQ:DH (9/12/2025, 8:00:01 PM)

After market: 4.15 0 (0%)

4.15

+0.02 (+0.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners37.13%
Inst Owner Change-4.12%
Ins Owners7.57%
Ins Owner Change15.62%
Market Cap591.29M
Analysts74.29
Price Target4.57 (10.12%)
Short Float %13.6%
Short Ratio7.96
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)68.99%
Min EPS beat(2)36.39%
Max EPS beat(2)101.59%
EPS beat(4)4
Avg EPS beat(4)42.37%
Min EPS beat(4)9.63%
Max EPS beat(4)101.59%
EPS beat(8)6
Avg EPS beat(8)24.89%
EPS beat(12)10
Avg EPS beat(12)29.77%
EPS beat(16)12
Avg EPS beat(16)22.12%
Revenue beat(2)1
Avg Revenue beat(2)0.94%
Min Revenue beat(2)-0.4%
Max Revenue beat(2)2.29%
Revenue beat(4)1
Avg Revenue beat(4)0.08%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)2.29%
Revenue beat(8)1
Avg Revenue beat(8)-1.12%
Revenue beat(12)2
Avg Revenue beat(12)-1.1%
Revenue beat(16)5
Avg Revenue beat(16)-0.73%
PT rev (1m)9.21%
PT rev (3m)9.21%
EPS NQ rev (1m)0.82%
EPS NQ rev (3m)-28.57%
EPS NY rev (1m)6.75%
EPS NY rev (3m)4.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.48%
Revenue NY rev (1m)0.52%
Revenue NY rev (3m)0.59%
Valuation
Industry RankSector Rank
PE 13.83
Fwd PE 15.55
P/S 2.41
P/FCF 14.33
P/OCF 9.39
P/B 1.95
P/tB N/A
EV/EBITDA 10.35
EPS(TTM)0.3
EY7.23%
EPS(NY)0.27
Fwd EY6.43%
FCF(TTM)0.29
FCFY6.98%
OCF(TTM)0.44
OCFY10.64%
SpS1.72
BVpS2.13
TBVpS-1.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.57%
ROE -100.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.35%
FCFM 16.85%
ROA(3y)-16.45%
ROA(5y)-10.62%
ROE(3y)-39.07%
ROE(5y)-24.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.22%
GM growth 5Y0.01%
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 4.1
Debt/EBITDA 3.51
Cap/Depr 39.87%
Cap/Sales 8.85%
Interest Coverage N/A
Cash Conversion 137.79%
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.65
Altman-Z -0.18
F-Score4
WACC9.26%
ROIC/WACCN/A
Cap/Depr(3y)14.76%
Cap/Depr(5y)11.57%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.22%
EPS Next Y-32.85%
EPS Next 2Y-12.68%
EPS Next 3Y-4.78%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.24%
Revenue growth 3Y14.91%
Revenue growth 5Y24.15%
Sales Q2Q%-4.69%
Revenue Next Year-4.79%
Revenue Next 2Y-2.09%
Revenue Next 3Y-0.46%
Revenue Next 5YN/A
EBIT growth 1Y63.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-12.53%
EBIT Next 3Y-4.78%
EBIT Next 5YN/A
FCF growth 1Y67.56%
FCF growth 3Y35.38%
FCF growth 5Y18.42%
OCF growth 1Y88.1%
OCF growth 3Y32.16%
OCF growth 5Y21.93%